Skip to main content
ClearPoint Neuro, Inc. logo

ClearPoint Neuro, Inc. — Investor Relations & Filings

Ticker · CLPT ISIN · US18507C1036 US Manufacturing
Open in API
Filings indexed 1,175 across all filing types
Latest filing 2026-05-21 Declaration of Voting R…
Country US United States of America
Listing US CLPT

About ClearPoint Neuro, Inc.

https://www.clearpointneuro.com/

ClearPoint Neuro, Inc. is a therapy-enabling company that provides a platform for precise, minimally invasive navigation and delivery of treatments to the brain and spine. Its core technology, the ClearPoint® Neuro Navigation System, is designed for use in both MRI suites and operating rooms, offering real-time visualization for neurosurgeons. The system facilitates a range of procedures, including the placement of deep brain stimulation (DBS) electrodes, laser ablation catheters, and the direct infusion of cell and gene therapies. The platform supports pharmaceutical and biotech partners in the development of neurological treatments by enabling accurate and controlled delivery of therapeutic agents directly to the target area.

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 82% confidence The document is a Form 8-K Current Report pursuant to Section 13/15(d) of the Exchange Act. It contains two primary items: Item 5.02 announcing changes in committee memberships and appointment of the Board Chair (board/management changes), and Item 5.07 providing detailed vote tallies from the Annual Meeting (election of directors, ratification of auditors, advisory vote on compensation, approval of the incentive plan). Although the Form addresses both management committee appointments and shareholder vote results, the most specific and prominent content is the official voting results from the Annual Meeting. This matches our “Declaration of Voting Results & Voting Rights Announcements” category. Therefore, the correct filing type is DVA.
2026-05-21 English
S-8
Regulatory Filings Classification · 85% confidence The document is a Form S-8 registration statement filed with the SEC to register additional shares under an employee incentive compensation plan. It is a regulatory compliance filing, not an annual report, proxy statement, share transaction notice, or earnings release. There is no dedicated category for a Securities Act registration statement, so this falls under the generic Regulatory Filings (RNS) category.
2026-05-20 English
10-Q - ClearPoint Neuro, Inc. (0001285550) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-13 English
ARS - ClearPoint Neuro, Inc. (0001285550) (Filer)
Annual Report
2026-04-23 English
SCHEDULE 13G/A - ClearPoint Neuro, Inc. (0001285550) (Subject)
Major Shareholding Notification
2026-03-26 English
4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
Director's Dealing
2026-03-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.